The latest precision medicine news

New Report – Analytics of the Microbiome Landscape

Palo Alto, CA, October 19, 2020 – The “Analytics of the Microbiome Landscape” report has been added to the enlightenbio LLC offering. This new report provides insights into the transformational microbiome...read more

PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care

Multiple targeted assays from Pillar Biosciences to be combined with the PierianDx platform to reduce time, cost, and complexity of clinical genomic testing St. LOUIS, MO. and NATICK, MA., OCTOBER 14, 2020 —PierianDx...read more

10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions

Signs Agreement to Acquire ReadCoor; Acquires Sweden’s CartaNA AB PLEASANTON, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) — Continuing on its mission of mastering biology to advance human health, 10x...read more

Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide

— World-class germline and somatic testing, liquid biopsy and tissue genomic profiling, now delivered from a single platform with unrivaled breadth and flexibility — SAN FRANCISCO, Oct. 5, 2020 /PRNewswire/...read more

Pacific Biosciences Launches the Sequel IIe System to Accelerate Adoption of Highly Accurate HiFi Sequencing

New system features advanced on-instrument data processing and cloud enablement to deliver HiFi data faster and with significant reduction in compute and data storage costs MENLO PARK, Calif., Oct. 05, 2020 (GLOBE...read more

Large-Scale Study Shows Guardant360 Liquid Biopsy Accelerates Clinical Trial Enrollment Compared to Tissue Biopsy

Nature Medicine Publication Reports that Liquid Biopsy More Than Doubles Clinical Trial Enrollment Rate Compared to Tissue Biopsy REDWOOD CITY, Calif.–(BUSINESS WIRE)–Oct. 5, 2020– Guardant...read more

BC Platforms Announces Colorado Center for Personalized Medicine Joins Global Data Partner Network BCRQUEST.com to advance Personalized Healthcare Research

October 1, 2020 – BC Platforms, a global leader in clinical and genomic data management, analytics and access, today announced that it has formed a new data partnership with the Colorado Center for Personalized...read more

Sophia Genetics Raises $110 Million In Oversubscribed New Funding Round

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding...read more

Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trials

Research alliance will leverage advanced data analytics and genomic testing to improve recruitment of patients in oncology clinical trials STAMFORD, CT — September 29, 2020 — Sema4, a patient-centered health...read more

Seven Bridges Advances Workflow Automation Capabilities to Make Complex Multi-Omic Analysis More Accessible to Broader Mix of Users

Seven Bridges RHEO™ Visual Interface Enables Biological Scientists and Developers to Work in a Single Environment at the Push of a Button BOSTON, September 23, 2020—Seven Bridges, the industry-leading bioinformatics...read more

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Accelerates Commercialization and Adoption of Transformative Multi-Cancer Screening Test with Potential to Detect More Cancers Earlier and Enable Better Outcomes Adds Multi-Disciplinary Team and Capabilities Harnessing...read more

Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation

CHICAGO & BURLINGTON, N.C.–(BUSINESS WIRE)–Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, and LabCorp (NYSE: LH), a...read more

NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites

Whole Transcriptome Atlas Service Based in NanoString’s Seattle Labs Premier Access Sites to Offer the Cancer Transcriptome Atlas Service from Labs Across the Globe SEATTLE–(BUSINESS WIRE)–NanoString...read more

GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering

MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced that it has filed a registration statement on Form S-1 with...read more

ClinSpec Dx receive £2.4m funding boost

Efforts to improve the early detection of cancer have received a significant boost with a £2.4 million funding deal to support the further development of innovative testing technology. Glasgow-based ClinSpec Diagnostics...read more

Invitae launches multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancer

SAN FRANCISCO, Sept. 3, 2020 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced enrollment has begun for a nationwide study to better understand the...read more

Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria

Partnership will expand 54gene’s sequencing-based research and molecular diagnostics capabilities with a focus on improving health outcomes through precision medicine CAMBRIDGE, England–(BUSINESS...read more

Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection

Proceeds will accelerate ongoing FDA registrational study of company’s first blood test for colorectal cancer screening and advance product pipeline Freenome will leverage its unique platform that characterizes both...read more

Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics

Lineagen is a provider of proprietary molecular diagnostics services for individuals showing clinical presentations consistent with neurodevelopmental disorders, including autism spectrum disorder (ASD) and other...read more

Biofidelity raises $12m in Series A financing to accelerate launch of disruptive cancer diagnostic technology

Supported by BlueYard Capital, Longwall Ventures and Agilent TechnologiesFunds to be used to bring technology to market, enabling a dramatic simplification of precision genetic testing to ensure many more cancer...read more

CancerIQ Raises $5M in VC Funding, Adds Strategic Hires to Epic Integration Team

The company plans to use the funding to further growth of its product offering and integration with EHRs and genetic testing partners. Chicago, August 13, 2020 — CancerIQ, an enterprise precision health platform for...read more

Mission Bio Raises $70M in Series C Funding Led by Novo Holdings to Accelerate Development of Cancer Therapies with Single-cell Multi-omics

Capital raised will scale the Tapestri Platform to advance the development of precision medicine through improved biomarker discovery and drug development SOUTH SAN FRANCISCO, Calif. (August 13, 2020) Mission Bio, Inc...read more

Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement

WALTHAM, Mass., Aug. 13, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its offer to acquire all of the ordinary shares of...read more

Atomwise Raises $123 Million in Series B Financing Co-Led by B Capital Group and Sanabil

New financing will enable Atomwise to further scale the largest artificial intelligence (AI)-driven drug discovery portfolio in history and expand $5 billion+ deal pipeline for small molecule drug discovery SAN...read more

Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Data Related to COVID-19 and Cancer

Research collaboration expanding to address urgent public health challenges including supporting FDA’s goal of rapid understanding of COVID-19 SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) — Syapse®, a real-world...read more

Helix Receives FDA Emergency Use Authorization for the HelixⓇ COVID-19 NGS Test, One of the First Sequencing-Based COVID-19 Tests

The high throughput test will be available in the Fall with next-day turnaround time and will enable Helix to scale its capacity to 100,000 tests per day SAN MATEO, Calif., Aug. 10, 2020 /PRNewswire/...read more

Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

Now FDA approved, the Guardant360 CDx delivers critical genomic information to oncologists from a simple blood draw REDWOOD CITY, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH)...read more

Our Top Selection of Precision Medicine News

Precision medicine, omics, and genetics news from around the world.